Page last updated: 2024-08-24

tepoxalin and Canine Diseases

tepoxalin has been researched along with Canine Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grauer, GF; Lomas, AL; Lyon, SD; Sanderson, MW1
Bushey, JJ; Cavatorta, D; Levine, CB; Loftus, JP; Sevier, CS; Wakshlag, JJ1
Budsberg, SC; Punke, JP; Reynolds, LR; Speas, AL1
Horvath-Ungerboeck, C; Shaw, DJ; Thoday, KL; van den Broek, AH1
Gilmour, MA; Lehenbauer, TW1
Dow, SW; Gustafson, DL; Hansen, RJ; Sottnik, JL; Thamm, DH1
Bushey, JJ; Goupil, RC; Peters-Kennedy, J; Wakshlag, JJ1
Bosmans, T; Duchateau, L; Gasthuys, F; Oosterlinck, M; Piron, K; Polis, I; Samoy, Y; Van Vynckt, D; Waelbers, T1
Brianceau, P; Cao, J; Grimm, KA; Kay-Mugford, PA; Lockwood, P; Weingarten, AJ1
Agnello, KA; Budsberg, SC; Reynolds, LR1

Trials

5 trial(s) available for tepoxalin and Canine Diseases

ArticleYear
Acute and chronic effects of tepoxalin on kidney function in dogs with chronic kidney disease and osteoarthritis.
    American journal of veterinary research, 2013, Volume: 74, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dog Diseases; Dogs; Drug Administration Schedule; Female; Male; Osteoarthritis; Pyrazoles; Renal Insufficiency, Chronic

2013
Effects of firocoxib, meloxicam, and tepoxalin on prostanoid and leukotriene production by duodenal mucosa and other tissues of osteoarthritic dogs.
    American journal of veterinary research, 2008, Volume: 69, Issue:9

    Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dog Diseases; Dogs; Duodenum; Female; Intestinal Mucosa; Leukotrienes; Male; Meloxicam; Osteoarthritis; Prostaglandins; Pyrazoles; Sulfones; Synovial Fluid; Thiazines; Thiazoles

2008
Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
    Veterinary dermatology, 2009, Volume: 20, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Pruritus; Pyrazoles

2009
Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs.
    American journal of veterinary research, 2009, Volume: 70, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dinoprostone; Dog Diseases; Dogs; Meloxicam; Pyrazoles; Thiazines; Thiazoles; Uveitis, Anterior

2009
Comparison of analgesic efficacy of epidural methadone or ropivacaine/methadone with or without pre-operative oral tepoxalin in dogs undergoing tuberositas tibiae advancement surgery.
    Veterinary anaesthesia and analgesia, 2012, Volume: 39, Issue:6

    Topics: Administration, Oral; Amides; Analgesics, Opioid; Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Injections, Epidural; Male; Methadone; Pain, Postoperative; Pyrazoles; Ropivacaine; Stifle

2012

Other Studies

5 other study(ies) available for tepoxalin and Canine Diseases

ArticleYear
The 5-lipoxygenase inhibitor tepoxalin induces oxidative damage and altered PTEN status prior to apoptosis in canine osteosarcoma cell lines.
    Veterinary and comparative oncology, 2016, Volume: 14, Issue:2

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Immunosuppressive Agents; Lipoxygenase Inhibitors; Osteosarcoma; Oxidative Stress; PTEN Phosphohydrolase; Pyrazoles

2016
Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft.
    Veterinary and comparative oncology, 2011, Volume: 9, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Bone Neoplasms; Cell Proliferation; Dog Diseases; Dogs; Hypoxia-Inducible Factor 1, alpha Subunit; In Vitro Techniques; Male; Mice; Osteosarcoma; Pyrazoles; Transplantation, Heterologous; Tumor Burden; Vascular Endothelial Growth Factors

2011
Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo.
    Veterinary pathology, 2012, Volume: 49, Issue:5

    Topics: Animals; Arachidonate 5-Lipoxygenase; Bone Neoplasms; Cell Proliferation; Cell Survival; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Female; Immunohistochemistry; Lipoxygenase Inhibitors; Male; Mice; Mice, Nude; Osteosarcoma; Pyrazoles; Retrospective Studies; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2012
Effect of preoperative administration of tepoxalin on hemostasis and hepatic and renal function in dogs.
    Veterinary therapeutics : research in applied veterinary medicine, 2004,Summer, Volume: 5, Issue:2

    Topics: Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dog Diseases; Dogs; Female; Hemostasis; Hemostasis, Surgical; Kidney; Liver; Male; Pain; Preanesthetic Medication; Pyrazoles; Random Allocation; Treatment Outcome

2004
In vivo effects of tepoxalin, an inhibitor of cyclooxygenase and lipoxygenase, on prostanoid and leukotriene production in dogs with chronic osteoarthritis.
    American journal of veterinary research, 2005, Volume: 66, Issue:6

    Topics: Analysis of Variance; Animals; Cross-Over Studies; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Leukotrienes; Lipoxygenase Inhibitors; Meloxicam; Osteoarthritis; Prostaglandins; Pyrazoles; Thiazines; Thiazoles

2005